MiR-18a inhibits BMP4 and HIF-1 α Normalizing Brain Arteriovenous Malformations.

Conclusions: MiR-18a may have significant clinical value in preventing, reducing and potentially reversing AVM.
PMID: 32755283 [PubMed - as supplied by publisher]

Source: Circulation Research - August 4, 2020 Category: Cardiology Authors: Marín-Ramos NI, Thein TZ, Ghaghada KB, Chen TC, Giannotta SL, Hofman F Tags: Circ Res Source Type: research